The full story
Our expertise is versatile, allowing us to dissect the different aspects of modern biology from emerging complex human diseases. Our proficiencies were developed in the research centers of excellent international universities’ medical schools including: the University of Chicago, the University of Illinois, the University of Augusta and Cancer Center of Georgia, Victor Segalen Bordeaux II University, the Pasteur Institute of Morocco, and the University of Tunis.
Scientific publications
2023:
New research manuscript under BioImmune Solutions Inc. was accepted for publication in collaboration with pathology department of Illinois university (USA) , to PLOS Pathogens on how Ehrlichia triggers the activation of NRF2 in infected hepatocytes, using gain of function strategy:
​
Ehrlichia Inhibit NRF2 Activation in Hepatocytes to Trigger Oxidative Stress and Promote Liver Injury and Sepsis. Aditya S, El Andaloussi A, Ismail N. 2023 (Accepted for publication)
​
2021:
​
Mesenchymal stem cell therapy ameliorates metabolic dysfunction and restores fertility in a PCOS mouse model through interleukin-10. Chugh RM, Park HS, El Andaloussi A, et al. Stem Cell Res Ther. 2021 Jul 7;12(1):388.
​
Human BM-MSC secretome enhances human granulosa cell proliferation and steroidogenesis and restores ovarian function in primary ovarian insufficiency mouse model. Park HS, Chugh RM, El Andaloussi A, et al. Sci Rep. 2021 Feb 25;11(1):4525.
​
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 2021 Jan;17(1):1-382.
​
​
Interferon Type I Regulates Inflammasome Activation and High Mobility Group Box 1 Translocation in Hepatocytes During Ehrlichia-Induced Acute Liver Injury. Kader M, El Andaloussi A, et al. Hepatol Commun. 2020 Sep 27;5(1):33-51
​